baber/WOPTO huggingface dataset:
Patent NZ-529783-A (NZ)
Title: A method and device for slicing food products using optoelectronic detection device to determine structure of the products
Inventor: WEBER GUNTHER
IPC: B26D5/00
Filed: 2002-04-11
Abstract: Product 11 such as ham or sausage is advanced toward the slicing region 31 to be cut by blade 29 into slices all of the same weight. The weight of a slice will depend on the thickness of the slice, the contour of the slice and the inner structure of the slice (proportion of fat to lean). Thus by measuring the contour and inner structure progressively during the slicing operation and controlling the slice thickness accordingly slices of constant weight can be attained even at high slicing rates. The contour and structure is measured by an optoelectronic detector using sequential detection procedures. The slicing region is illuminated by the radiation source 19 and radiation reflected from the cut surfaces of the slices to be cut off and from the marginal regions of the slices is detected by detector 23 and evaluated by processor 25. Moreover, in at least one detection procedure, the illumination is effected in a plurality of components, such as wavelength, polarisation, time of illumination, that are independent of the direction of the light, and that differ from one another at least with respect to one illumination parameter.
Patent NZ-538338-A (NZ)
Title: Vent valve
Inventor: MULLER MICHAEL PAUL
IPC: F16K31/385
Filed: 2002-07-31
Abstract: The invention concerns an air transfer valve which automatically vents accumulated air from pressurized liquid reticulation pipelines or vessels. The valve (10) has a housing (12) which is connectable to the pipeline or vessel. The housing has a first outlet (38) venting to atmosphere and a control chamber (60) which is exposed to internal pressure in the housing via a control chamber inlet. A first valve closure (34) can move to open and close the first outlet. This valve closure is exposed to control chamber pressure tending to move it to close the first outlet and to internal housing pressure tending to move it to open the first outlet. When the housing is pressurized the first valve closure (34) is maintained in a closed position by virtue of an unbalanced pressure force acting on it that is attributable to exposure of the valve closure to atmosphere through the first outlet. There is also a control chamber outlet (36) from the control chamber (60) to atmosphere. This outlet is larger than the control chamber inlet. The valve also incorporates a float (20) in the housing (12) which is arranged to be buoyed up by liquid entering the housing from the pipeline and a second valve closure (24) carried by the float which is arranged to open and close the control chamber outlet (36) in response to movement of the float caused by variations in the level of liquid in the housing. Downward movement of the float (20) in response to a drop in liquid level in the housing (12), attributable to accumulation of air in the housing, causes the second valve closure (24) to open the control chamber outlet (36). This allows the control chamber (60) to vent to atmosphere. The pressure in the control chamber (60) drops relative to the internal housing pressure and creates an unbalanced pressure force on the valve closure (34) which causes it to open the outlet (38). The housing can then vent to atmosphere via the outlet (38).
Patent NZ-544620-A (NZ)
Title: Single frame sling chair
Inventor: WANG OLIVER
Filed: 2006-01-11
Abstract: A sling chair that includes a back frame member having a pair of side rails 14 held parallel to each other by first 28 and second 38 cross bar members is disclosed. In one embodiment the second cross bar includes upper 52 and lower 53 portions between which an edge of a sling 33 can be held. A second edge of the sling is positioned in a gap between the first cross bar and a support bar 30 detachably secured to the first cross bar. The sling has loops formed along its top and bottom edges through which rods are inserted to hold the sling securely in the back frame member.
Patent NZ-562764-A (NZ)
Title: Liquid container with light emitting portion to emit light towards a receptor on a recording apparatus
Inventor: WATANABE KENJIRO
IPC: B41J2/175
Filed: 2006-06-01
Abstract: Disclosed is a liquid container (1) detachably mountable to a recording apparatus to which a plurality of liquid containers are detachably mountable, the recording apparatus includes an apparatus antenna and photoreceptor means (210). The liquid container includes a container antenna (102) which communicates wirelessly with the apparatus antenna; an information storing portion storing individual information of the liquid container; a light emitting portion (101); and a controller (103). The controller controls light emission of the light emitting portion in response to a correspondence between a signal indicative of the individual information supplied through the container antenna and the information stored in the information storing portion.
Patent NZ-568985-A (NZ)
Title: Disc implant
Inventor: CHRISTENSEN FINN BJARKE
IPC: A61F2/44
Filed: 2006-12-08
Abstract: A disc implant 1 for total disc replacement includes first and second inter-vertebral elements 2 each having outer fusion surfaces and internal coupling surfaces, and a coupling 4, 5 which flexibly connects the inter-vertebral elements. The coupling includes a protuberance on the first element and a concave indentation on the second element for receiving the protuberance of the first element. The first element may include a flange that is received within a slot in the second element, or alternatively a ball or plate positioned between the first and second elements. Following surgery, the relative movability of said two inter-vertebral elements is decreased over time, as bone ingrowth occurring around the implant and specifically through osseointegrative sections 6 gradually decreases the movability of the elements relative to each other. The osseointegrative sections are openings or incisions which occupy at least 10% of the volume of the inter-vertebral elements.
Patent NZ-569262-A (NZ)
Title: Carbohydrate composition for flat glucose response
Inventor: VAN LAERE KATRIEN MARIA JOZEFA
IPC: A23L1/09
Filed: 2006-12-20
Abstract: Disclosed is a low-glycemic available carbohydrate composition containing the following components (i) 5-60 wt.percent of one or more monosaccharides selected from monosaccharides other than glucose and fructose (ii) 10-75 wt.percent of oligosaccharides having a length of 2 to 20 anhydromonose units, at least half of which are anhydroglucose units linked at their alpha-1-position to the 1-, 3-, 5- or 6-position of another anhydromonose unit; wherein component (ii) comprises 10-60 wt.percent of one or more of trehalulose, palatinose, turanose and leucrose and (iii) 0-75 wt.percent of other available carbohydrates. Also disclosed is the use of said composition for the manufacture of a pharmaceutical composition for the treatment of diabetes, obesity, insulin resistance or postgprandial glucose response.
Patent NZ-575507-A (NZ)
Title: 4-substituted phenoxyphenylacetic acid derivatives
Inventor: DOHERTY GEORGE
IPC: A61K31/10
Filed: 2007-08-21
Abstract: Disclosed is diphenyl ether of general formula (I) or a salt thereof, wherein: R1, R2, R7, R8, R9, R10 and A are defined in the specification for treating inflammatory conditions, immune disorders, asthma, allergic rhinitis, eczema, psoriasis, atopic dermatitis, fever, sepsis, systemic lupus erythematosus, diabetes, rheumatoid arthritis, multiple sclerosis, atherosclerosis, transplant rejection, inflammatory bowel disease, cancer, viral infection, thrombosis, fibrosis, flushing, Crohn's disease, ulcerative colitis, chronic obstructive pulmonary disease, inflammation, pain, conjunctivitis, nasal congestion and urticaria. Also disclosed is a process for the preparation of said compound which comprises (a) reacting an aryl cyano ester with a corresponding phenol in the presence of a base; or (b) reducing a corresponding diphenylether; or (c) cleaving a succinimide; or (d) reacting a corresponding amine with a sulfonyl or acid, (e) coupling a diphenylether with an amine or carboxylic acid or (f) coupling and aryl chloride with the corresponding phenol ester or (g) coupling phenyl aldehyde, with a in the presence of a base, followed by converting the carbonyl group to a carboxyl group; or (i) reacting a corresponding diphenylether with a Negishi organozinc compound, in the presence of a palladium (0) catalyst, or with a boronic acid in the presence of a base and a palladium (0) catalyst, or (j) treating a diazonium salt with hydrogen fluoride; and removing any protecting group or groups and, if desired, forming a salt.
Patent NZ-579779-A (NZ)
Title: Filtration system including fine apertured screen
Inventor: JOHNSON WARREN THOMAS
IPC: B01D63/04
Filed: 2008-04-04
Abstract: A filtration system (4) for removing fine solids from a liquid suspension comprising: a vessel for containing the liquid suspension; one or more permeable membranes (5) within the vessel; means for providing a pressure differential across walls of the membranes such that some of the liquid suspension passes through the walls of the membranes to be drawn off as permeate; a screen (8) positioned in a flow path of the liquid suspension through to the membrane walls; and means for withdrawing permeate from the membranes. The screen is a fine screen with an aperture size of between 625 µm2 to 25 x 106 µm2.
Patent NZ-584729-A (NZ)
Title: Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer
Inventor: MULLAN MICHAEL J
IPC: A61K31/44
Filed: 2008-10-03
Abstract: Disclosed is a pharmaceutical composition comprising optically active nilvadipine and a pharmaceutically acceptable carrier, the pharmaceutical composition comprising an excess of (-)-nilvadipine relative to (+)-nilvadipine, wherein the pharmaceutical composition is in a form suitable for parenteral, oral or interperitoneal administration. Also disclosed is The use of a therapeutically effective amount of enantiomerically-enriched (-)-nilvadipine in the manufacture of a composition for reducing the risk of cerebral amyloidogenic disease or condition resulting from A beta deposition, A beta neurotoxicity and microgliosis in an animal or human suffering from traumatic brain injury, wherein the composition is for administration following the acute head injury; or in an animal or human diagnosed with a risk for developing cerebral amyloidogenic disease or condition; or in an animal or human afflicted with a cerebral amyloidogenic disease or condition.
Patent NZ-585636-A (NZ)
Title: Cable connection system and associated cable terminal lugs for mains power cables
Inventor: OGDEN BRUCE JAMES
IPC: H01R13/40
Filed: 2010-05-26
Abstract: Disclosed is a cable connection system includes a pair of electrically conductive primary cable terminal lugs. Each primary cable terminal lug has a longitudinally extending primary barrel defining a primary tunnel for receipt of a mains cable core strand; a primary palm longitudinally extending from the primary barrel and defining a primary palm front face and a primary palm rear face; a terminal block mounting aperture extending through the primary palm from the primary palm front face to the primary palm rear face; at least one primary threaded barrel aperture extending through a wall of the primary barrel into the primary tunnel; and a primary mains cable securing fastener which is threadedly received in each of the primary threaded barrel apertures. Each primary mains cable securing fastener has a leading end which extends into the primary tunnel. The cable connection system further includes an electrically conductive terminal block which has a front, a rear, an upper and a lower face. The terminal block has a pair of laterally spaced primary lug mounting apertures extending from the terminal block rear face towards the terminal block front face. The terminal block has a plurality of longitudinally extending service cable apertures extending from the lower face towards the upper face for receipt of a plurality of service cables. The terminal block also includes a plurality of securing means, each being associated with a respective service cable aperture. The connection system also includes a pair of terminal block mounting fasteners each configured to extend from the primary palm rear face of one of the primary cable terminal lugs through the terminal block mounting aperture of the primary cable terminal lug to be threadedly received in one of the primary lug mounting apertures of the terminal block so as to secure the terminal block to each of the primary cable terminal lugs with the terminal block rear face engaging the primary palm front face of each of the primary cable terminal lugs.
Patent NZ-586714-A (NZ)
Title: Determining milk processing stages by measuring vacuum levels
Inventor: GIBBS RUSSELL NORMAN
IPC: G01F1/34
Filed: 2010-07-09
Abstract: Disclosed is a method of determining a current stage of a milking process having a plurality of stages. The method includes: measuring a vacuum level associated with the process; receiving an operational state of at least one valve; determining the current stage by comparing the vacuum level and state of the valve with predetermined criteria associated with the plurality of stages; and issuing an indication of the current stage of the milking process. Further disclosed is an apparatus to carry out this method.
Patent NZ-590933-A (NZ)
Title: Aircraft taxiing system using a separate engine with variable thrust angle relative to fuselage located in tail for moving aircraft into position on the ground
Inventor: BHARGAVA BRIJ B
IPC: B64C30/00
Filed: 2009-06-12
Abstract: An aircraft taxiing system for use while the plane is on the ground or airport runway. A separate engine (70) is located in the tail section of the fuselage (60), mounted so that the aircraft horizontal tail control stabilisers (69) and vertical tail control surface (68). The engine can be a turbine. The taxi thrust system has a maximum rated thrust output not exceeding 15% of the total take-off thrust of the flight engines. The weight of the taxi engines does not exceed 10% of the flight engine weight. The taxiing engine provides thrust substantially along the axis of the airplane body to move the aircraft forward. The engine contains a rotationally movable vane (80) to deflect the jet thrust stream between an azimuth angle (82) to assist steering. The taxi engine is not used when the aeroplane is taking off, in flight or landing, the flight engines are not used for taxiing the aircraft.
Patent NZ-592018-A (NZ)
Title: Method for evaporating and distilling fluids using a heat pump allowing the fluid to evaporate at a low temperature
Inventor: HEGGEN OLA
IPC: B01D1/00
Filed: 2009-08-31
Abstract: 592018 Disclosed is a method for evaporation and/or distillation of liquids by means of a heat pump (2). Low temperature heat is utilised by means of a heat pump (2) by using the condenser (4) of the heat pump to evaporate liquids in an evaporator (4') at a pressure lower than the atmospheric pressure, and thus at a lower evaporation temperature. A pump or a compressor (10) after the evaporator (4') together with a pressure reducing device (9) at the inlet of the evaporator (4') ensures lower evaporation pressure. To fully utilise the heat energy from the heat pump (2), the liquids may be preheated in heat exchangers (5a, 5b) before the pressure reducing means (9), or as part of the same means. To achieve higher temperature and pressure of the evaporated liquids, the liquids are further compressed by means of compressors (10), or alternatively by heating in intermediate heat exchangers (11) in order to achieve the desired temperature level. The method includes eliminating saturation of the evaporated liquids before the evaporated liquids enter the compressor (10) by further heating of the evaporated liquids leaving the heat exchanger (11) of the liquids evaporator (4').
Patent NZ-596468-A (NZ)
Title: Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
Inventor: YBARRONDO BELEN
IPC: G01N33/50
Filed: 2010-05-13
Abstract: Patent No. 596468 Disclosed is an in vitro method for determining the sensitivity of a cell to a compound that modulates HER2 activity, the method comprising: (a) determining the activation level of HER2 or p95HER2 in a cellular extract produced from the cell; and (b) comparing the activation level of HER2 or p95HER2 determined in step (a) to a first reference activation level of HER2 or p95HER2 in a compound-sensitive cell and to a second reference activation level of HER2 or p95HER2 in a compound-resistant cell, wherein the presence of a similar or lower level of HER2 or p95HER2 activation in the cellular extract compared to the first reference activation level of HER2 or p95HER2 indicates that the cell is sensitive to the compound, wherein the presence of a similar or higher level of HER2 or p95HER2 activation in the cellular extract compared to the second reference activation level of HER2 or p95HER2 indicates that the cell is resistant to the compound, and wherein determining the activation level of p95HER2 in step (a) comprises: (i) incubating the cellular extract with a plurality of beads specific for an extracellular domain (ECD) binding region of full-length HER2; (ii) removing the plurality of beads from the cellular extract, thereby removing full-length HER2 to form a cellular extract devoid of full-length HER2; (iii) incubating the cellular extract devoid of full-length HER2 with a dilution series of capture antibodies specific for an intracellular domain (ICD) binding region of full-length HER2 to form a plurality of captured receptors, wherein the capture antibodies are restrained on a solid support; (iv) incubating the plurality of captured receptors with detection antibodies comprising activation state-independent antibodies and activation state dependent antibodies specific for an ICD binding region of full-length HER2 to form a plurality of detectable capture receptors, wherein the activation state-independent antibodies are labelled with a facilitating moiety, the activation state-dependent antibodies are labelled with a first member of a signal amplification pair, and the facilitating moiety generates an oxidizing agent which channels to an reacts with the first member of the signal amplification pair; (v) incubating the plurality of detectable captured receptors with a second member of the signal amplification pair to generate an amplified signal; and (vi) detecting the amplified signal generated from the first and second members of the signal amplification pair.
Patent NZ-599913-A (NZ)
Title: Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
Inventor: HUANG LIMING
IPC: A01N43/82
Filed: 2010-11-15
Abstract: Disclosed herein is a compound of formula I-R or I-S wherein the variables are defined in the specification; the use thereof in the treatment of multiple sclerosis, transplant rejection, or acute respiratory distress syndrome by activation or agonism of a sphingosine-1-phosphate receptor subtype 1; and a method of preparing said compound comprising a chiral reduction of an oxo group bound to the sic-membered saturated ring of a tetrahydronaphthalene moiety with a ruthenium catalyst to form a compound of formaul VI-R or VI-S, functional group interconversion of the alcohol to an azide with diphenylphosphoryl azide to form a compound of formula VII-R or VII-S, when Z is –CN, reacting the compound of formula VII-R or VII-S with a hydroxylamine or a hydroxylamine hydrochloride to forma a hydroxyamidine at the phenyl carbon to which Z is attached to form a compound of formula VIII-R or VIII-S followed by reaction with substituted benzoic acid and a coupling reagent to form a compound of formula IX-R or IX-S. In one embodiment the compound is 5-(3-(2-(hydroxymethyl)pyridin-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxy-benzonitrile.
Patent NZ-603645-A (NZ)
Title: Compressor case lining
Inventor: ROOKSTOOL CRAIG
IPC: F01D25/24
Filed: 2011-05-31
Abstract: A compressor for use with a gas turbine engine is provided. The compressor includes a compressor case (40), which is comprised of a first (42) and second half. A plurality of vanes (56) are positioned radially about the interior (52) of the compressor case. A lining is applied to the interior of the compressor casing. The lining comprises a mixture of a carbon fibre filler, a resin, a hardener, a graphite filler, a silicon dioxide filler and a diethylaminoethanol catalyst. The lining allows a minimal clearance to be between the lining and wheel blade tips spinning within the compressor casing. The carbon fiber in the lining allows the lining to withstand a high number of temperature cycles.
Patent NZ-605258-A (NZ)
Title: Pipe fitting
Inventor: TURK MARC TIMOTHY
IPC: F16L19/065
Filed: 2011-06-28
Abstract: A compression pipe fitting is provided. The fitting comprises a body (12) defining one or more sockets for receiving an end of a pipe (22), a clamping nut (14) and a grip ring (16). The socket is encircled by a threaded face, and is internally adapted to receive a compressible O-ring (20). The nut (14) can be screwed onto the threaded face of the socket and has an internal tapered surface (30) while the grip ring has a complimentally tapered surface which, when the nut is tightened onto the threaded face, bears upon the grip ring compressing it against the pipe and compressing the O-ring located within the socket.
Patent NZ-629114-A (NZ)
Title: Shelf structure for a merchandiser
Inventor: LAMONTAGNE RICK M
IPC: A47F3/00
Filed: 2014-03-12
Abstract: A shelf (40) for a merchandiser or display cabinet is disclosed. By enclosing and capturing a skeleton structure between skins shelf is formed as an integral unit to increase the load carrying capabilities of the shelf. The shelf includes a skin that defines a support surface of the shelf, and a skeleton structure to which the skin is attached. The skeleton structure includes a first end bracket (50) and a second end bracket (50) that is spaced from and disposed opposite the first end bracket. The skeleton structure further includes an internal bracket (54) that has a first end (110) coupled to the first end bracket adjacent a rear end of the first end bracket, and a second end (114) coupled to the second end bracket adjacent a rear end of the second end bracket. The internal bracket extends forward from the respective rear ends toward a front of the shelf. In a second embodiment the internal bracket is connected between a rear and font bracket.
Patent NZ-629155-A (NZ)
Title: Broom
Inventor: KHOURY EDWARD JOSEPH
IPC: A47L13/00
Filed: 2013-02-28
Abstract: A broom (10) is disclosed. The broom (10) comprises a head (12) and a handle (14). The head (12) comprises a first portion (16) having a plurality of bristles and a second portion (17) extending outwardly from the first portion (17) at an angle thereto. A recess (28) extends from adjacent a first end of the second portion (17) to adjacent a second end of the second portion (17) and a scraper blade (30) is fixed at least partially within the recess (28) such that at least portions of longitudinal ends of the scraper blade (30) are covered.
Patent NZ-707090-A (NZ)
Title: Synthetic lethality and the treatment of cancer
Inventor: BERTHIAUME LUC
IPC: A61K31/7088
Filed: 2013-10-30
Abstract: Described herein are compounds, compositions and methods for treatment of cancer. Also described are methods and uses for identifying subject with cancer that are suitable for treatment with the compounds, composition and methods are described herein. In one aspect of the present invention, there is provided a method of treating a subject having a cancer deficient in NMT2, comprising: administering to said subject an NMT inhibitor. In particular, the present invention provides for the use of an NMT inhibitor in the preparation of a medicament, wherein the NMT inhibitor comprises an NMT1 inhibitor, wherein said inhibitor comprises DDD86481, for the treatment of a cancer deficient in NMT2 in a subject.